Prostate Imaging Articles & Analysis
9 news found
RSIP Vision, an experienced leader in driving innovation for medical imaging through advanced Artificial Intelligence (AI) and computer vision solutions, today announces a new tool for prostate MRI analysis. The tool performs segmentation of the prostate, its sub-sections, and lesions. It analyzes the lesions’ intensity, restriction, size, ...
Gauden will retain his current responsibilities as President, Research and Development and Chief Scientific Officer and report to Bracco Imaging CEO Fulvio Renoldi Bracco. Terri Wilson, President of BED Inc. ...
The collaboration allows Focal Healthcare to develop a smart 3D ultrasound imaging platform for point of care use. TORONTO, CANADA – Focal Healthcare, known globally as a leading innovator of image-guided prostate cancer technology, is diversifying their product line by developing an AI-based 3D ultrasound imaging ...
Of 60 patients originally planned for ADT monotherapy, only 25% (15) were still due to receive ADT monotherapy after Axumin PET/CT imaging. Axumin, a novel amino acid-based radiopharmaceutical, is FDA-approved for PET imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) ...
In collaboration with urologists and using a consumer-centric approach, Akumin’s goal is to redefine the delivery of prostate care through diagnostic imaging, minimally invasive treatment, and post-treatment monitoring,” said Riadh Zine, President and Chief Executive Officer of Akumin. ...
Exact Imaging wishes to congratulate all of the clinicians and researchers who are leveraging micro-ultrasound to improve the diagnostic pathway for prostate cancer. ...
TORONTO, CANADA -- (March 23, 2021) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announces $5.1M in financing provided by BDC Capital, through the Bridge Financing Program, and Export Development Canada (EDC). ...
Work from Home – Exact Imaging has gone virtual and will do so until health officials give us the “all clear” to gather again at our workplaces. ...
Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology firm focusing on cancer diagnostics and therapeutics, today announced that the NIH awarded a 2-year, $2M SBIR grant to CTT to develop a new agent that will help diagnose and monitor metastatic prostate cancer. CTT1057, a positron emission tomography (PET) imaging agent, discovered by ...